Patients may experience nausea, vomiting, diarrhea, constipation, stomach pain, reduced appetite, fatigue, or other concerns
Anti-musk Abs are thought to block the binding of other components, including collagen Q and low-density lipoprotein receptor-related protein 4 (LRP4) that facilitate the role of MuSK in the neuromuscular junction [149, 150]
Additionally, tirzepatide may benefit atherosclerosis and lower the risk of major adverse cardiac events
Semaglutide and other GLP-1s can change eating and drinking patterns
Full tissue-level effects generally take the length of the cycle, 4 to 12 weeks